Dual D2/H3 Receptor Antagonists (Angita)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameDual D2/H3 Receptor Antagonists (Angita)

Drug Alias Namedual dopamine D2 receptor/histamine H3 receptor antagonists (Angita)dual D2/H3 receptor antagonists (Angita)Dual Dopamine D2 Receptor/Histamine H3 Receptor Antagonists (Angita)AG-0098

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine D2 receptor antagonistsHistamine H3 receptor antagonists

TargetsHistamine H3 receptorDopamine D2 receptor

Therapy Area/IndicationsSchizophrenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAngita Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAngita Pharmaceuticals

Active IndicationsN/A

Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A